SCHEMBL1189771

SCHEMBL1189771

O=C1N[C@H]2CCCC[C@H]2NC1=O

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.55
PKM P14618 1/20 0.55
PARP1 P09874 1/20 0.47
LMNA P02545 2/20 0.39
TSHR P16473 1/20 0.39
OPRM1 P35372 4/20 0.36
OPRL1 P41146 4/20 0.36
MAPK1 P28482 1/20 0.33
OPRK1 P41145 3/20 0.32
OPRD1 P41143 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CA4 P22748 1/20 0.32
DAO P14920 2/20 0.31
MAPT P10636 1/20 0.31
KMT2A Q03164 1/20 0.31
POLB P06746 1/20 0.30
GAA P10253 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2904793 1.00 ALDH1A1 (0.55) ALDH1A1PKMPARP1LMNATSHR
SCHEMBL27848116 1.00 ALDH1A1 (0.55) ALDH1A1PKMPARP1LMNATSHR
SCHEMBL19546338 0.97 ALDH1A1 (0.52) ALDH1A1PKMPARP1LMNATSHR
SCHEMBL19546339 0.97 ALDH1A1 (0.52) ALDH1A1PKMPARP1LMNATSHR
SCHEMBL12601191 0.84 ALDH1A1 (0.52) ALDH1A1PKMPARP1LMNATSHR
SCHEMBL22579511 0.84 ALDH1A1 (0.52) ALDH1A1PKMPARP1LMNATSHR
SCHEMBL31093217 0.84 ALDH1A1 (0.52) ALDH1A1PKMPARP1LMNATSHR
SCHEMBL2881411 0.84 ALDH1A1 (0.52) ALDH1A1PKMPARP1LMNATSHR
SCHEMBL13587011 0.79 LMNA (0.53) ALDH1A1PKMPARP1LMNATSHR
SCHEMBL6737826 0.78 PARP1 (0.46) ALDH1A1PKMPARP1LMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2217226-B1 PEPTIDE DEFORMYLASE INHIBITORS GLAXOSMITHKLINE LLC (US) 2015-07-22 EP disclosed
US-20130045962-A1 PEPTIDE DEFORMYLASE INHIBITORS GLAXOSMITHKLINE LLC 2013-02-21 US disclosed
US-7893056-B2 Peptide deformylase inhibitors GLAXOSMITHKLINE LLC (US) 2011-02-22 US disclosed
US-20090306066-A1 PEPTIDE DEFORMYLASE INHIBITORS GLAXOSMITHKLINE LLC 2009-12-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130045962-A1 PEPTIDE DEFORMYLASE INHIBITORS PDF, DPEP1, DHPS ALDH1A1 985/4885PKM 2293/4885PARP1 1272/4885
US-20090306066-A1 PEPTIDE DEFORMYLASE INHIBITORS PDF, DHPS, PADI3 ALDH1A1 1567/4885PKM 1508/4885PARP1 2571/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.